Improving care at scale: process evaluation of a multi-component quality improvement intervention to reduce mortality after emergency abdominal surgery (EPOCH trial).pdf (1.68 MB)
Download file

Improving care at scale: process evaluation of a multi-component quality improvement intervention to reduce mortality after emergency abdominal surgery (EPOCH trial).

Download (1.68 MB)
journal contribution
posted on 30.01.2019, 09:41 by T. J. Stephens, C. J. Peden, R. M. Pearse, S. E. Shaw, T. E. F. Abbott, E. L. Jones, D. Kocman, G. Martin, EPOCH trial group
BACKGROUND: Improving the quality and safety of perioperative care is a global priority. The Enhanced Peri-Operative Care for High-risk patients (EPOCH) trial was a stepped-wedge cluster randomised trial of a quality improvement (QI) programme to improve 90-day survival for patients undergoing emergency abdominal surgery in 93 hospitals in the UK National Health Service. METHODS: The aim of this process evaluation is to describe how the EPOCH intervention was planned, delivered and received, at both cluster and local hospital levels. The QI programme comprised of two interventions: a care pathway and a QI intervention to aid pathway implementation, focussed on stakeholder engagement, QI teamwork, data analysis and feedback and applying the model for improvement. Face-to-face training and online resources were provided to support senior clinicians in each hospital (QI leads) to lead improvement. For this evaluation, we collated programme activity data, administered an exit questionnaire to QI leads and collected ethnographic data in six hospitals. Qualitative data were analysed with thematic or comparative analysis; quantitative data were analysed using descriptive statistics. RESULTS: The EPOCH trial did not demonstrate any improvement in survival or length of hospital stay. Whilst the QI programme was delivered as planned at the cluster level, self-assessed intervention fidelity at the hospital level was variable. Seventy-seven of 93 hospitals responded to the exit questionnaire (60 from a single QI lead response on behalf of the team); 33 respondents described following the QI intervention closely (35%) and there were only 11 of 37 care pathway processes that > 50% of respondents reported attempting to improve. Analysis of qualitative data suggests QI leads were often attempting to deliver the intervention in challenging contexts: the social aspects of change such as engaging colleagues were identified as important but often difficult and clinicians frequently attempted to lead change with limited time or organisational resources. CONCLUSIONS: Significant organisational challenges faced by QI leads shaped their choice of pathway components to focus on and implementation approaches taken. Adaptation causing loss of intervention fidelity was therefore due to rational choices made by those implementing change within constrained contexts. Future large-scale QI programmes will need to focus on dedicating local time and resources to improvement as well as on training to develop QI capabilities. EPOCH TRIAL REGISTRATION: ISRCTN80682973 https://doi.org/10.1186/ISRCTN80682973 Registered 27 February 2014 and Lancet protocol 13PRT/7655.

Funding

The EPOCH trial was funded by the National Institute of Health Research (NIHR) of the United Kingdom (HS&DR - 12/5005/10). The funder had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; or in the preparation, review or approval of the manuscript. TA is supported by a Medical Research Council and British Journal of Anaesthesia Clinical Research Training Fellowship. SS is funded by grants from the Wellcome Trust and NIHR.

History

Citation

Implementation Science, 2018, 13 (1), pg. 142

Author affiliation

/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences

Version

VoR (Version of Record)

Published in

Implementation Science

Publisher

BMC (part of Springer Nature)

eissn

1748-5908

Acceptance date

05/10/2018

Copyright date

2018

Available date

30/01/2019

Publisher version

https://implementationscience.biomedcentral.com/articles/10.1186/s13012-018-0823-9

Notes

The Correction to this article has been published in Implementation Science 2018 13:148 https://implementationscience.biomedcentral.com/articles/10.1186/s13012-018-0840-8 http://hdl.handle.net/2381/45631;The datasets during and/or analysed during the current study are available from the corresponding author on reasonable request; however, some data will need to be redacted to anonymise all trial sites. All other materials referred to in this paper are either available as Additional file 1 or can be found at www.epochtrial.org.

Language

en

Usage metrics

Categories

Licence

Exports